Table 2. Proteins identified in lung cancer cohort Nasosorption FX-i samples.

Excel file containing proteins identified in the lung cancer cohort described in Chapter 5 of the thesis entitled: "The Nasal Proteome as a Source of Biomarkers for SARS-CoV-2 and Lung Cancer". Tabs containing proteins identified in all samples, unique to individual disease groups and present in two of three disease groups. Nasal mucus from Nasosorption FX-i devices from patients with lung cancer, post-lung cancer resection and matched controls was eluted and processed for mass spectrometry analysis using S-Trap. Samples were analysed in a data-dependent manner and subsequently analysed using Proteome Discoverer software.